Testing 20921 for admin 2

Study on the Efficacy of an Investigational Medication for Chronic Pain

Testing 20921 for admin 2
Recruiting
18 years - 99 years
All
Phase 2
10 participants needed
1 Location

Brief description of study.

Testing for condition

Detailed description of study

 

Eligibility of study

You may be eligible for this study if you meet the following criteria:

  • Conditions: acne,cancer,diabetes
  • Age: 18 years - 99 years
  • Gender: All
Updated on 19 Feb 2024. Study ID: NCT20921
  • Who can participate: Adults aged 18 to 65 years who have been diagnosed with chronic pain for at least six months and are not currently taking any other pain management medications are eligible to participate.
  • Study details: Participants will be randomly assigned to receive either the investigational medication or a placebo. The study will involve regular assessments of pain levels and overall health to determine the medication's efficacy and safety.

Pre-Screener

Check if you are eligible Enter contact details Select a study center Select best time to contact

Are you able to lay on your back for up to an hour?

Select the response that best describes you.


Preview complete

The prescreener preview is complete. You may now close the preview.

Default Content Message Here